Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?

被引:1
作者
Shalem, Tzippora [1 ]
Cohen, Daniel L. [2 ]
Epstein-Rigbi, Na'ama [3 ,4 ]
Elizur, Arnon [3 ,4 ]
Eindor-Abarbanel, Adi [1 ]
Broide, Efrat [1 ,2 ,4 ]
Richter, Vered [2 ,4 ]
机构
[1] Shamir Assaf Harofeh Med Ctr, Jecheskiel Sigi Gonczarowski Pediat Gastroenterol, IL-70300 Zerifin, Israel
[2] Shamir Assaf Harofeh Med Ctr, Gonczarowski Family Inst Gastroenterol & Liver Dis, IL-70300 Zerifin, Israel
[3] Shamir Assaf Harofeh Med Ctr, Inst Allergy Immunol & Pediat Pulm, Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
Eosinophilic esophagitis (EoE); Oral immunotherapy (OIT); Proton pump inhibitor (PPI); Treatment efficacy; ALLERGY;
D O I
10.1007/s00431-023-05228-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Oral immunotherapy (OIT) may induce eosinophilic esophagitis (EoE). Proton pump inhibitors (PPIs) are an effective treatment for EoE. However, the effect of PPI treatment is not well established in patients with EoE induced by OIT. Our primary aim was to compare the clinical, endoscopic, and histological response rates to PPIs in children with EoE induced by OIT (EoE+OIT) versus EoE patients without OIT (EoE-OIT). The secondary aims are to describe the clinical and histological features of EoE+OIT. Demographic, clinical, endoscopic, and histological findings of patients with EoE in the gastroenterology clinic at Shamir Medical Center between March 2015 and December 2022 were collected. Comparisons were performed between EoE+OIT and EoE-OIT patients. The study included 42 children (74% male, mean age 11.2), of whom 31 had EoE-OIT and 11 had EoE+OIT. There were no significant differences between groups regarding sex, comorbidities, symptoms, or endoscopic and histological characteristics at diagnosis. All 42 children were treated with PPIs after diagnosis with or without diet changes. The rates of any clinical response were 83.9% and 90.1% in the EoE-OIT group and EoE+OIT group, respectively (p = 1.0). The rate of any endoscopic response was 74.2% for EoE-OIT and 81.8% for EoE+OIT (p = 0.54). Histologically, PPIs were even more effective in the EoE+OIT group, where only 18.2% had no histological response at all compared to 51.6% in the EoE-OIT group (p = 0.1).Conclusion: PPI treatment is as effective in EoE with OIT as it is in EoE due to other etiologies.What is Known:& BULL; Proton pump inhibitor (PPI) treatment is effective for achieving clinical response and histologic remission in some patients with eosinophilic esophagitis (EoE).& BULL; EoE has also been reported to be triggered by oral immunotherapy (OIT).What is New:& BULL; PPI treatment in EoE with OIT is as effective as treatment for EoE due to other etiologies.
引用
收藏
页码:5409 / 5416
页数:8
相关论文
共 16 条
  • [1] Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
    Chu, Derek K.
    Wood, Robert A.
    French, Shannon
    Fiocchi, Alessandro
    Jordana, Manel
    Waserman, Susan
    Brozek, Jan L.
    Schuenemann, Holger J.
    [J]. LANCET, 2019, 393 (10187) : 2222 - 2232
  • [2] A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis
    Dellon, Evan S.
    Gupta, Sandeep K.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) : 2149 - 2160
  • [3] Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment
    Dellon, Evan S.
    Cotton, Cary C.
    Gebhart, Jessica H.
    Higgins, Leana L.
    Beitia, RoseMary
    Woosley, John T.
    Shaheen, Nicholas J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (01) : 31 - 39
  • [4] British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults
    Dhar, Anjan
    Haboubi, Hasan N.
    Attwood, Stephen E.
    Auth, Marcus K. H.
    Dunn, Jason M.
    Sweis, Rami
    Morris, Danielle
    Epstein, Jenny
    Novelli, Marco R.
    Hunter, Hannah
    Cordell, Amanda
    Hall, Sharon
    Hayat, Jamal O.
    Kapur, Kapil
    Moore, Andrew Robert
    Read, Carol
    Sami, Sarmed S.
    Turner, Paul J.
    Trudgill, Nigel J.
    [J]. GUT, 2022, 71 (08) : 1459 - 1487
  • [5] Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy
    Echeverria-Zudaire, L. A.
    Fernandez-Fernandez, S.
    Rayo-Fernandez, A.
    Munoz-Archidona, C.
    Checa-Rodriguez, R.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2016, 44 (06) : 531 - 536
  • [6] Treatment of oral immunotherapy-associated eosinophilic esophagitis
    Epstein-Rigbi, Na'ama
    Elizur, Arnon
    Levy, Michael B.
    Nachshon, Liat
    Koren, Yael
    Shalem, Zippi
    Broide, Efrat
    Goldberg, Michael R.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (04) : 1303 - 1305.e2
  • [7] Allergen-Specific lmmunotherapies for Food Allergy
    Feuille, Elizabeth
    Nowak-Wegrzyn, Anna
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2018, 10 (03) : 189 - 206
  • [8] Long-term medical treatment efficacy in patients with eosinophilic oesophagitis and oral food immunotherapy
    Garcia Vega, Marta
    Fernandez-Fernandez, Sonia
    Echeverria Zudaire, Luis
    Bracamonte Bermejo, Teresa
    Cano del aguila, Beatriz
    Vega Hernandez, Pilar
    Ortega Sanchez, Estefania
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (12) : 1440 - 1443
  • [9] Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis
    Gutierrez-Junquera, Carolina
    Fernandez-Fernandez, Sonia
    Luz Cilleruelo, M.
    Rayo, Ana
    Echeverria, Luis
    Borrell, Belen
    Roman, Enriqueta
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 67 (02) : 210 - 216
  • [10] Hirano I, 2020, ANN ALLERG ASTHMA IM, V124, P416, DOI 10.1016/j.anai.2020.03.020